TDC
CANF

Thompson Davis & Co’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Thompson Davis & Co’s Portfolio CANF Stock Details CANF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3
Closed -$9K – 715
2018
Q2 		$9K Buy
+3
New +$12K 0.02% 436

Other funds holding CANF

TAM
Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
AF
Advisornet Financial Minnetonka, Minnesota $1.93B AUM 18.43% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Thompson Davis & Co's CANF Position: Q3 2018 in Review

Thompson Davis & Co sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q3 2018, closing a stake of 3 shares — an estimated $9K sold.

Thompson Davis & Co first reported a position in CANF in Q2 2018 and held it in 1 quarter. The position peaked at $9K in Q2 2018. 10 funds tracked by Wall St. Rank hold CANF as of Q3 2018.

  • Thompson Davis & Co reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q3 2018 after selling out during the quarter.
  • Thompson Davis & Co sold 3 Can-Fite BioPharma American Depositary Shares shares in Q3 2018, an estimated $9K.
  • Thompson Davis & Co first reported a position in Can-Fite BioPharma American Depositary Shares in Q2 2018 and held it in 1 quarter.
  • Thompson Davis & Co's Can-Fite BioPharma American Depositary Shares position peaked at $9K in Q2 2018.
  • 10 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.